Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Avrobio Inc
(NQ:
AVRO
)
1.400
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Avrobio Inc
< Previous
1
2
3
Next >
AVROBIO Receives Rare Pediatric Disease Designation from the U.S. FDA for AVR-RD-05, a Gene Therapy for Mucopolysaccharidosis Type II (MPSII) or Hunter Syndrome
November 03, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Announces the Appointment of Essra Ridha, M.D., MRCP, FFPM, as Chief Medical Officer
October 26, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO to Present at the Jefferies Virtual Gene Therapy/Editing Summit
October 20, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Reports New Interim Safety Data Across Investigational Gene Therapies for Fabry and Gaucher Disease Type 1
October 19, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO to Present New Clinical and Preclinical Data Across Multiple Programs at the ESGCT 28th Annual Congress
October 06, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 05, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 03, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO to Participate at Four Upcoming Investor Conferences
September 01, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Reports Second Quarter 2021 Financial Results and Provides Business Update
August 05, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO to Present at Two Upcoming Investor Conferences in August
August 02, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 08, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO to Present at the JMP Securities Life Sciences Conference
June 10, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Reports First Quarter 2021 Financial Results and Provides Business Update
May 13, 2021
From
AVROBIO, Inc.
Via
Business Wire
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against AVROBIO, Inc. and Encourages Investors with Losses to Contact the Firm
May 12, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 06, 2021
From
AVROBIO, Inc.
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against AVROBIO, Inc. and Encourages Investors with Losses to Contact the Firm
May 05, 2021
From
The Schall Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against AVROBIO, Inc. and Encourages Investors with Losses to Contact the Firm
May 04, 2021
From
The Schall Law Firm
Via
Business Wire
BREAKING ALERT: Rosen Law Firm Encourages AVROBIO, Inc. Investors with Losses to Inquire About Class Action Investigation – AVRO
May 04, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
AVROBIO Provides Regulatory Update on Investigational AVR-RD-01 for Fabry Disease
May 03, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO to Present Clinical and Preclinical Data at the ASGCT 24th Annual Meeting
April 27, 2021
From
AVROBIO, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.